Glaukos Corporation (GKOS) is a pioneering ophthalmic medical technology and pharmaceutical company based in San Clemente, California, focused on developing innovative treatments for glaucoma, corneal disorders, and retinal diseases. The company specializes in minimally invasive surgical techniques and advanced drug delivery systems, significantly improving patient outcomes. With a commitment to research and development, Glaukos is well-positioned to address the increasing demand for effective ophthalmic therapies, establishing itself as a vital competitor in the sector and contributing to efforts against blindness and vision impairment.
Click "Analyze" to generate stock analysis
GKOS Price Trend and Signals
GKOS Option Volumes & Open Interests (aggregated)
GKOS Put Call Ratios and IV (aggregated)
GKOS Financials
2025-10-24Somewhat Bearishprice_signal
Yearly low detected.
2025-10-24Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-24Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-24Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-24Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.
2025-10-23Somewhat Bearishprice_signal
Yearly low detected.
2025-10-21Bearishmacd_signal
Dead cross below zero detected.
2025-10-21Somewhat Bearishprice_signal
Yearly low detected.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.